AAAAAA
Results:
1-18
|
Results: 18
SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO
Authors:
ASCHELE C
BALDO C
SOBRERO AF
DEBERNARDIS D
BORNMANN WG
BERTINO JR
Citation: C. Aschele et al., SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO, Clinical cancer research, 4(5), 1998, pp. 1323-1330
SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO
Authors:
ASCHELE C
BALDO C
SOBRERO AF
DEBERNARDIS D
BORNMANN WG
BERTINO JR
Citation: C. Aschele et al., SCHEDULE-DEPENDENT SYNERGISM BETWEEN RALTITREXED AND IRINOTECAN IN HUMAN COLON-CANCER CELLS IN-VITRO, Clinical cancer research, 4(5), 1998, pp. 1323-1330
Authors:
SOBERO A
FRASSINETI GL
GIULANI R
CAROTI C
RAVAIOLI A
LANFRANCO C
CAPRIONI F
ALGHISI A
ARNOLDI E
BARNI S
GALLO L
PESSI MA
GUGLIELMI A
TURCI D
CORTESI E
MILANDRI C
ASCHELE C
GROSSI F
LABIANCA R
Citation: A. Sobero et al., RANDOMIZED COMPARISON BETWEEN SEQUENTIAL MTX-]FU AND SCHEDULE SPECIFIC BIOCHEMICAL MODULATION IN ADVANCED COLORECTAL-CANCER (ACRC), Annals of oncology, 9, 1998, pp. 157-157
Authors:
ASCHELE C
GUGLIELMI A
FRASSINETI GL
MILANDRI C
AMADORI D
LABIANCA R
VINCI M
TIXI L
CAROTI C
CIFERRI E
VERDI E
ROSSO R
SOBRERO A
Citation: C. Aschele et al., SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A MULTICENTRIC PHASE-II STUDY, British Journal of Cancer, 77(2), 1998, pp. 341-346
Authors:
SOBRERO AF
ASCHELE C
BERTINO JR
Citation: Af. Sobrero et al., FLUOROURACIL IN COLORECTAL-CANCER A TALE OF 2 DRUGS - IMPLICATIONS FOR BIOCHEMICAL MODULATION, Journal of clinical oncology, 15(1), 1997, pp. 368-381
Authors:
GUGLIELMI A
ASCHELE C
GROSSI F
TIXI L
SOBRERO A
Citation: A. Guglielmi et al., ALTERNATING BOLUS AND CONTINUOUS-INFUSION 5-FLUOROURACIL - A STRATEGYTO OVERCOME RESISTANCE TO THIS FLUOROPYRIMIDINE IN ADVANCED COLORECTAL-CANCER PATIENTS, Cytotechnology, 19(3), 1996, pp. 215-219
Authors:
SOBRERO AF
ASCHELE C
GUGLIELMI AP
MORI AM
TIXI LM
BOLLI EA
ROSSO R
MAMMOLITI S
ROLLANDI GA
BERTOGLIO S
BRUZZI P
BERTINO JR
Citation: Af. Sobrero et al., SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL - A PHASE-II STUDY IN ADVANCED COLORECTAL-CANCER, Clinical cancer research, 1(9), 1995, pp. 955-960
Authors:
GUGLIELMI A
ASCHELE C
MORI A
BALDO C
RUSSO P
DEBERNARDIS D
VALENTI M
BRUNO S
TAVERNA M
ROSSO R
SOBRERO A
Citation: A. Guglielmi et al., IN-VITRO SYNERGISM BETWEEN 5-FLUOROURACIL AND NATURAL BETA-INTERFERONIN HUMAN COLON-CARCINOMA CELLS, Clinical cancer research, 1(11), 1995, pp. 1337-1344
Authors:
SOBRERO A
ASCHELE C
GUGLIELMI A
MORI A
TIXI L
BOLLI E
GROSSI F
Citation: A. Sobrero et al., CIRCUMVENTION OF RESISTANCE TO 5-FLUOROURACIL BY SCHEDULE-ORIENTED BIOCHEMICAL MODULATION IN ADVANCED COLON-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 305-305
Authors:
CAMPORA E
CHIARA S
ASCHELE C
Citation: E. Campora et al., ONDANSETRON FOR THE CONTROL OF DACARBAZINE-INDUCED EMESIS, European journal of cancer, 31A(10), 1995, pp. 1720-1721
Authors:
ASCHELE C
SOBRERO A
LOMBARDO C
SANTI L
Citation: C. Aschele et al., HOW UNIFORM ARE POSTGRADUATE TRAINING-PROGRAMS IN MEDICAL ONCOLOGY INTHE EUROPEAN UNION, Annals of oncology, 6(5), 1995, pp. 441-443
Authors:
ASCHELE C
GUGLIELMI A
MORI A
TIXI L
BOLLI E
CIFERRI E
FAZIO S
MUNICINO O
SOBRERO A
Citation: C. Aschele et al., THE 2 SIDES OF 5-FLUOROURACIL - BOLUS AND CONTINUOUS-INFUSION, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 53-59
Authors:
BOLLI E
SACCOMANNO S
MONDINI G
ASCHELE C
GUGLIELMI A
LIGAS B
CONNIO M
MORI A
ROSSO R
SOBRERO A
TIXI L
PUGLIESE V
Citation: E. Bolli et al., 5-FLUOROURACIL PLUS 5-METHYLTETRAHYDROFOLATE IN ADVANCED PANCREATIC-CANCER, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 339-342
Authors:
ROSSO R
MAZZEI T
SOBRERO A
MINI E
CARTEI G
CONTE P
LABIANCA R
CARTEI F
FALCONE A
PANCERA G
BARSANTI G
DICOSTANZO F
GUGLIELMI A
BOLLI E
TIXI L
ASCHELE C
RIBECCO A
PERITI P
Citation: R. Rosso et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 30A(3), 1994, pp. 338-343
Authors:
SOBRERO AF
ASCHELE C
GUGLIELMI AP
MORI AM
MELIOLI GG
ROSSO R
BERTINO JR
Citation: Af. Sobrero et al., SYNERGISM AND LACK OF CROSS-RESISTANCE BETWEEN SHORT-TERM AND CONTINUOUS EXPOSURE TO FLUOROURACIL IN HUMAN COLON ADENOCARCINOMA CELLS, Journal of the National Cancer Institute, 85(23), 1993, pp. 1937-1944
Authors:
MORI A
BERTOGLIO S
GUGLIELMI A
ASCHELE C
BOLLI E
TIXI L
ROSSO R
SOBRERO A
Citation: A. Mori et al., ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 179-180
Authors:
WANG FS
ASCHELE C
SOBRERO A
CHANG YM
BERTINO JR
Citation: Fs. Wang et al., DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE EXPRESSION - A NOVEL MECHANISM OF FLUOROURACIL RESISTANCE, Cancer research, 53(16), 1993, pp. 3677-3680
Authors:
ASCHELE C
SOBRERO A
FADERAN MA
BERTINO JR
Citation: C. Aschele et al., NOVEL MECHANISM(S) OF RESISTANCE TO 5-FLUOROURACIL IN HUMAN COLON CANCER (HCT-8) SUBLINES FOLLOWING EXPOSURE TO 2 DIFFERENT CLINICALLY RELEVANT DOSE SCHEDULES, Cancer research, 52(7), 1992, pp. 1855-1864
Risultati:
1-18
|